You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
AstraZeneca
Johnson and Johnson
Express Scripts
Mallinckrodt

Last Updated: September 24, 2023

Investigational Drug Information for AZD-8330


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for AZD-8330?

AZD-8330 is an investigational drug.

There have been 33 clinical trials for AZD-8330. The most recent clinical trial was a Phase 3 trial, which was initiated on September 15th 2021.

The most common disease conditions in clinical trials are Lung Neoplasms, Small Cell Lung Carcinoma, and Ovarian Neoplasms. The leading clinical trial sponsors are AstraZeneca, National Cancer Institute (NCI), and Samsung Medical Center.

There are one hundred and sixteen US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for AZD-8330
TitleSponsorPhase
Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2AstraZenecaPhase 3
Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2Botswana Ministry of HealthPhase 3
Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2Botswana Harvard AIDS Institute PartnershipPhase 3

See all AZD-8330 clinical trials

Clinical Trial Summary for AZD-8330

Top disease conditions for AZD-8330
Top clinical trial sponsors for AZD-8330

See all AZD-8330 clinical trials

US Patents for AZD-8330

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AZD-8330 ⤷  Try a Trial Organic compositions to treat beta-catenin-related diseases Arrowhead Pharmaceuticals, Inc. (Pasadena, CA) ⤷  Try a Trial
AZD-8330 ⤷  Try a Trial Minimal volume reprogramming of mononuclear cells Fate Therapeutics, Inc. (San Diego, CA) ⤷  Try a Trial
AZD-8330 ⤷  Try a Trial 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]- pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy Oncoceutics, Inc. (Philadelphia, PA) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
AstraZeneca
Johnson and Johnson
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.